Cofoe Medical Technology Co., Ltd. Class A

As of June 30, 2026, Cofoe Medical Technology Co. Ltd. Class H carries a market capitalization of 6.96B, placing it among publicly traded companies globally. Its enterprise value stands at 4.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cofoe Medical Technology Co. Ltd. Class H's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Cofoe Medical Technology Co. Ltd. Class H has 235.90M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Cofoe Medical Technology Co. Ltd. Class H maintains a current ratio of 2.63, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Cofoe Medical Technology Co. Ltd. Class H recorded 59.79M in income tax expense.

These figures are as of the close on October 22, 2026.

As of June 30, 2026, Cofoe Medical Technology Co. Ltd. Class H holds 3.54B in cash and equivalents against 1.00B in total debt, resulting in a net debt position of -1.98B. Total book value stands at 6.39B, with working capital of 3.32B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Cofoe Medical Technology Co. Ltd. Class H paid dividends of 1.40 per share.